LETITIA MEYER: Open Payments
NPI 1467978189 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 19 payments from 8 companies in 2025. Trend: 2023 $329 · 2024 $339 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Abbott Laboratories | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $28 |
| Lilly USA, LLC | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: FARXIGA, XIFAXAN, FREESTYLE LIBRE 2, BREZTRI, Kerendia, Cologuard Collection Kit, Rybelsus, AIRSUPRA.
Industry payments across AZ — which companies pay providers there.
